Home › Idiopathic Pulmonary Fibrosis › Oklahoma
Idiopathic Pulmonary Fibrosis clinical trials in Oklahoma
4 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Oklahoma.
Cities in Oklahoma
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Oklahoma City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Oklahoma, Oklahoma City
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Oklahoma City, OK, Oklahoma City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.